$1.25
-3.5%Solésence, Inc., formerly Nanophase Technologies Corporation, is a developer and manufacturer of clean, inclusive, mineral-based skincare and makeup products. The company partners with global and indie brands, leveraging its proprietary Active Stress Defense™ technology suite to bring environmental protection beauty products to market.
Negative free cash flow despite positive earnings raises concerns about cash generation ability or heavy capital requirements.
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
Significant FCF decline raises concerns. Urgent review needed of operational performance and capital allocation.
Significant working capital drain. Growth may be consuming cash through inventory buildup or receivables extension—monitor closely.
Cash flow concerns: Despite profitability, the company is burning cash. Review working capital management, CapEx levels, and sustainability of current operations.
SLSN • NASDAQ
| Solesence, Inc. Common Stock Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
OPERATING ACTIVITIES | |||||
1.8M | 4.2M | -4.4M | -2.6M | 2.3M | |
897K | 928K | 742K | 567K | 454K | |
575K | 725K | 773K | 625K | 160K | |
0.0 | 0.0 | 0.0 | 2.6M | -49K | |
-11.8M | -3.9M | 869K | -2.8M | -564K | |
-8.6M | 2M | -2M | -1.7M | 2.3M | |
INVESTING ACTIVITIES | |||||
-2.1M | -4.6M | -1.1M | -2.8M | -1.9M | |
-2.1M | -4.6M | -1.1M | -2.8M | -1.9M | |
FINANCING ACTIVITIES | |||||
323K | 0.0 | 0.0 | 0.0 | 0.0 | |
10.3M | -5.8M | 2.5M | -111K | -981K | |
0.0 | 2.1M | 73K | 6.1M | 234K | |
10.6M | 2.3M | 2.6M | 6M | -747K | |
CASH FLOW SUMMARY | |||||
-121K | -313K | -464K | 1.5M | -300K | |
1.4M | 1.7M | 2.2M | 657K | 957K | |
1.3M | 1.4M | 1.7M | 2.2M | 657K | |
-10.7M | -2.6M | -3.1M | -4.5M | 447K |
SLSN - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
10-Q 10-Q 2026 Q1 Q1 | May 12, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 12, 2026 | May 12, 2026 | 2026 | |
8-K 8-K 2026 N/A | April 29, 2026 | April 24, 2026 | 2026 | |
10-K/A 10-K/A 2025 FY (Amended) FY | April 23, 2026 | December 31, 2025 | 2025 | |
10-K 10-K 2025 FY FY | March 31, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 31, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2025 N/A | December 03, 2025 | November 24, 2025 | 2025 | |
8-K 8-K 2025 N/A | December 01, 2025 | November 21, 2025 | 2025 | |
8-K 8-K 2025 N/A | November 13, 2025 | November 11, 2025 | 2025 | |
10-Q 10-Q 2025 Q3 Q3 | November 12, 2025 | September 30, 2025 | 2025 |
Continue your SLSN research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.